Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000030336 | SCV000053003 | likely benign | Atrial septal defect 7 | 2011-08-18 | criteria provided, single submitter | clinical testing | Converted during submission to Likely benign. |
Labcorp Genetics |
RCV000030336 | SCV000288515 | benign | Atrial septal defect 7 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000301072 | SCV000342973 | likely benign | not specified | 2016-07-07 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000301072 | SCV000516622 | likely benign | not specified | 2018-02-12 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Ambry Genetics | RCV000617707 | SCV000735245 | likely benign | Cardiovascular phenotype | 2023-08-21 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Ce |
RCV003389673 | SCV001500861 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | NKX2-5: BP4, BP7, BS1 |